Antimicrobial resistance is a global threat to public health
Antimicrobial resistance (AMR) is the ability of a microorganism (such as bacteria, viruses, and some parasites) to stop an antimicrobial (such as antibiotics, antivirals and antimalarials) from working against it (WHO 2019). New resistance mechanisms are emerging and spreading globally, threatening our ability to treat infectious diseases, resulting in prolonged illness, disability, and death. Also, without effective antibiotics, modern medical procedures such as general surgery, organ transplantation and chemotherapy become very high risk.
Responses to AMR
Global awareness of the severity of the problem is urgently needed, and important actors such as the WHO have already set up large campaigns in order to raise public awareness. The Innovative Medicines Initiative (IMI) has invested heavily in AMR, and the AMR Accelerator programme complements and builds on the achievements of IMI’s New Drugs for Bad Bugs programme, which also focuses on AMR.